Lung Cancer Trials Ask AI to find trials
Active Not RecruitingNot applicableNCT05407168
Official study title

Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Study summary

This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.

Ask AI to explain this study
Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedBest Practice and Health Promotion and Education

Plus 1 other study approaches.

Who it may be forLung Carcinoma

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 2, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Not applicable

Interventional

Where is it offered?4 U.S. locations

Locations may change over time.

Who runs it?OHSU Knight Cancer Institute

Study sponsor

01
Study overview

What this study is about

Purpose
Health Services Research
Study type
Interventional
Phase
Not applicable
Sponsor
OHSU Knight Cancer Institute
Interventions being studied
Other: Best Practice; Other: Health Promotion and Education; Other: Questionnaire Administration
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • AIM 1: Suspected lung cancer
  • AIM 1: English fluency
  • AIM 1: \> 6-month life expectancy
  • AIM 1: Score of ≥ 3 on the cognitive impairment screener
  • AIM 2 PARTICIPANTS: Participation in Aim 1
  • AIM 2 CLINICIANS: Discussing lung cancer treatment decisions with Aim 1 participants

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Hillsboro Medical CenterHillsboro, Oregon
  • Adventist Health PortlandPortland, Oregon
  • OHSU Knight Cancer InstitutePortland, Oregon
  • Portland VA Medical CenterPortland, Oregon

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 2, 2026. Always confirm current availability with the study team.

View original record ↗